• 2018-2020
    The total revenue from merchandise sales in 2020 was US$783 million.
    Detection Kit for 2019 Novel Coronavirus (2019-nCoV) RNA (PCR-Fluorescence) was included in the World Health Organization (WHO) emergency use listing on May 14, 2020, and Daan Gene became one of the first Chinese enterprises to be included in the listing.
    Daan Gene was commissioned by the Red Cross Society of China to assist Iraq in building 2019-nCoV nucleic acid testing laboratories. Mr. Yang Penghui, Director of Technical Services, accompanied the Chinese medical team to Iraq to fight the 2019-nCoV.

  • 2019
    The Journal of Molecular Diagnosis and Therapy published by Daan Gene was included in the "Chinese core journals of science and technology".

  • 2018
    Daan Gene has undertaken major scientific and technological projects such as the prevention and treatment of AIDS, viral hepatitis and other major national infectious diseases.
    DA9100 Electrochemical Gene Chip Instrument" was recognized as the first batch of innovative products in Guangdong Province by the Department of Science and Technology of Guangdong Province.

  • 2013-2017
    Daan Chuanggu was selected as one of the ten excellent cases of new economy of China in 2016.

  • 2015
    The Ebola virus nucleic acid test kit jointly developed by Daan Gene and the Chinese Center for Disease Control and Prevention obtained the medical device registration certificate.
    Daan Gene Investment Department established Guangzhou Daan Chuanggu Enterprise Management Co., Ltd.

  • 2013
    Daan Gene was selected as one of the first national enterprises with intellectual property advantages.

  • 2008-2012
    Daan Gene was recognized as an "Innovative Enterprise in Guangdong Province" by the Department of Science and Technology of Guangdong Province.

  • 2011
    Daan Gene was approved by the National Development and Reform Commission to establish a "Clinical Molecular Diagnosis National and Local Joint Engineering Laboratory".

  • 2009
    Daan Gene became the first company in China to develop fluorescent quantitative PCR reagents against influenza A H1N1.

  • 2008
    Daan Gene organized its technical team to rush to Sichuan for undertaking earthquake disaster relief after a strong earthquake hit Sichuan Province. Under the unified command and arrangement of the headquarters, they devoted themselves to this earthquake relief work.

  • 2003-2007
    Daan Gene wholly acquired "Zhongshan Biological Engineering Co., Ltd." and entered the field of immunological diagnosis (ELISA).
    The Chlamydia Tracomatis Fluorescence PCR Diagnostic Kit and Human Cytomegalovirus Fluorescence PCR Diagnostic Kit produced by Daan Gene obtained the CE certificate, which provided a strong guarantee for Daan Gene to open and enter the European market. This was the first time in China to obtain this high-level (IVDD Class B) CE certificate.

  • 2006
    Daan Gene passed BSI (UK) ISO13485 Quality assessment system certification and obtained ISO13485 certificate.
    Guangzhou Daan Clinical Laboratory Center Co., Ltd. was established, and Daan Gene officially entered the field of medical laboratory services.

  • 2005
    Daan Gene and Guangzhou Sanyuan Technology Co., Ltd. jointly invested to establish Guangzhou Dayuan Food Safety Technology Co., Ltd. to enter the field of food safety testing.

  • 2004
    Daan Gene was listed on the Shenzhen Stock Exchange, becoming the first listed company run by colleges and universities in Guangdong Province.

  • 2003
    Daan Gene made significant contributions in the battle against SARS: it was the first to develop the coronavirus fluorescent quantitative PCR reagents in China; it provided 69,000 tests for 86 domestic disease control centers and medical and health institutions for free; participated in the fight against SARS in Beijing, and successfully screened out many people with fever.
    Daan Gene established its holding subsidiary "Guangzhou Darui Antibody Engineering Technology Co., Ltd." to develop time-resolved immunofluorescence technique and enter the field of in vitro diagnosis of healthy birth and childbirth.
    The company headquarters was moved from Huihua Building in Dongshan District to No.19 Xiangshan Road, Science City, and obtained the drug manufacturing certificate for the new address.
    The antibody technology research center of Guangzhou Darui Antibody Engineering Technology Co., Ltd., a subsidiary of Daan Holdings, was established.

  • 1998-2002
    The National Development and Reform Commission approved the "Fluorescent Gene Probe Quantitative PCR Diagnostic Kit Technology Industrialization Demonstration Project" to be included in the national high-tech industry development project plan.
    Sun Yat-sen University was merged with Sun Yat-Sen Medical University, and the company was changed as DaAn Gene Co., Ltd. of Sun Yat-sen University Co., Ltd.

  • 2000
    The company name was changed from Sun Yat-sen Medical University Technology Development Company to Sun Yat-sen Medical University Technology Development Co., Ltd.

  • 1999
    Daan Gene obtained the new drug certificate and trial production approval of the product Hepatitis B Virus Nucleic Acid (PCR) Fluorescence Detection Kit, which was the first new drug certificate of this technology in China, and also the first commercialized diagnostic kit of this technology in the world.

  • 1998
    Five fluorescent PCR kits produced by Daan Gene, including hepatitis B virus, hepatitis C virus, Mycobacterium tuberculosis, Chlamydia tracomatis and Neisseria gonorrhoeae, were certified by National Institute for the Control of Pharmaceutical and Biological Products, marking the first time that fluorescent quantitative PCR kits were submitted for approval in China.

  • 1993-1997
    Daan Gene made breakthrough in the core technology of fluorescent quantitative PCR, and established a stable technology platform of Medical Bioengineering Research Center of the Ministry of Health.

  • 1996
    Daan Gene appointed Mr. Cheng Gang to undertake the research and development of new nucleic acid amplification technology, marking the first company in China to carry out the research and development of fluorescence quantitative PCR technology.

  • 1995
    The Science and Technology Center of the Ministry of Health approved Daan Gene to establish its Gene Diagnosis Technology Department.

  • 1994
    Daan cooperated with 20 hospitals to establish PCR laboratories within half a year, and carried out 15 PCR technology courses and 25 academic lectures.

  • 1993
    Daan Gene (originally DaAn Gene) originated from the Sun Yat-sen Medical University in Guangzhou in 1993. Mr. He Yunshao was appointed as the general manager to take charge of the operation and management of "Sun Yat-sen Medical University Technology Development Company", focusing on molecular diagnosis technology as its strategic development direction.

  • +86 16602030197
  • +86 20 32068126
  • marketing@daangene.com
  • No.19, Xiangshan Road, Science Park, High & New Technology Development District, Guangzhou, Guangdong, P.R. China
Copyright c 2021Daan Gene Co., Ltd. Powered by vancheer